Debt Financing - Aldagen
Investment Firm
Overview
Aldagen develops regenerative cell therapies for inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure.
Announced Date
Jan 13, 2012
Funding Type
Debt Financing
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Aldagen raised $585004 on 2012-01-13 in Debt Financing
Aldagen develops regenerative cell therapies for inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure.
Company Funding History
9
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 23, 2011 |  Debt Financing - Aldagen | - | 1.1M | |
| Jan 13, 2012 | Debt Financing - Aldagen | - | 585.0K | |
| Sep 01, 2007 | Series C - Aldagen | 4 | - | 9.0M |
| Apr 23, 2008 | Series D - Aldagen | 4 | - | 18.4M |
Recent Activity
There is no recent news or activity for this profile.